Literature DB >> 9220168

Detection of serum antibodies to CagA and VacA and of serum neutralizing activity for vacuolating cytotoxin in patients with Helicobacter pylori-induced gastritis.

M Donati1, S Moreno, E Storni, A Tucci, L Poli, C Mazzoni, O Varoli, V Sambri, A Farencena, R Cevenini.   

Abstract

Thirty patients with dyspepsia, with histological diagnosis of gastritis, and with endoscopic diagnosis of peptic ulcer disease (PUD) (n = 13) or nonulcer dyspepsia (NUD) (n = 17) were admitted to the study. Helicobacter pylori vacuolating cytotoxin-producing strains (Tox+) were isolated from 14 (46.7%) patients, whereas non-cytotoxin-producing (Tox-) H. pylori strains were isolated from the remaining patients. Of 30 patients studied, 20 (66.7%) had serum cytotoxin neutralizing activity in vitro. Fourteen patients with Tox+ H. pylori strains showed serum cytotoxin neutralizing activity and serum immunoglobulin G (IgG) and IgA antibodies reactive with both 87-kDa H. pylori vacuolating cytotoxin (VacA) and 128-kDa cytotoxin-associated gene product (CagA) by immunoblotting using native enriched preparations of VacA and CagA proteins from H. pylori culture supernatants as the antigens. A 94-kDa antigen cross-reacting with the 87-kDa VacA protein could be demonstrated in culture supernatant with immune sera from humans and animals. All patients (n = 10) lacking serum neutralizing activity were also negative for IgG or IgA against VacA antigen, whereas 6 of the 10 patients showed IgG serum antibody responses against CagA antigen. The prevalence of antibodies to VacA and CagA antigens was significantly (P < 0.001) higher in patients with gastritis (20 and 26 patients for VacA and CagA, respectively, of 30 patients) than in H. pylori culture-negative controls (0 of 27 for both VacA and CagA) and in randomly selected blood donors (17 and 21 for VacA and CagA, respectively, of 120 subjects). All patients with PUD had antibodies to CagA, whereas 13 of 17 (76.5%) patients with NUD had anti-CagA antibodies. Serum IgG antibodies to VacA were present in 9 (69.2%) patients with PUD of 13 patients and in 11 (64.7%) patients with NUD of 17 patients. Anti-CagA antibodies seemed to correlate better with PUD than anti-VacA antibodies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9220168      PMCID: PMC170554          DOI: 10.1128/cdli.4.4.478-482.1997

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  33 in total

1.  The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases.

Authors:  J F Weel; R W van der Hulst; Y Gerrits; P Roorda; M Feller; J Dankert; G N Tytgat; A van der Ende
Journal:  J Infect Dis       Date:  1996-05       Impact factor: 5.226

2.  Detection in an enzyme immunoassay of an immune response to a recombinant fragment of the 128 kilodalton protein (CagA) of Helicobacter pylori.

Authors:  Z Xiang; M Bugnoli; A Ponzetto; A Morgando; N Figura; A Covacci; R Petracca; C Pennatini; S Censini; D Armellini
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-10       Impact factor: 3.267

3.  Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin.

Authors:  Z Xiang; S Censini; P F Bayeli; J L Telford; N Figura; R Rappuoli; A Covacci
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

4.  Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease.

Authors:  P Ghiara; M Marchetti; M J Blaser; M K Tummuru; T L Cover; E D Segal; L S Tompkins; R Rappuoli
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

5.  Pathological significance and molecular characterization of the vacuolating toxin gene of Helicobacter pylori.

Authors:  S H Phadnis; D Ilver; L Janzon; S Normark; T U Westblom
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

6.  Cross-reactive antigens shared by Pseudomonas aeruginosa, Helicobacter pylori, Campylobacter jejuni, and Haemophilus influenzae may cause false-positive titers of antibody to H. pylori.

Authors:  H K Johansen; A Nørgaard; L P Andersen; P Jensen; H Nielsen; N Høiby
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

7.  Antigen recognition during progression from acute to chronic infection with a cagA-positive strain of Helicobacter pylori.

Authors:  H M Mitchell; S L Hazell; T Kolesnikow; J Mitchell; D Frommer
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

8.  Serologic detection of infection with cagA+ Helicobacter pylori strains.

Authors:  T L Cover; Y Glupczynski; A P Lage; A Burette; M K Tummuru; G I Perez-Perez; M J Blaser
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

9.  Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer.

Authors:  A Covacci; S Censini; M Bugnoli; R Petracca; D Burroni; G Macchia; A Massone; E Papini; Z Xiang; N Figura
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

10.  Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease.

Authors:  J L Telford; P Ghiara; M Dell'Orco; M Comanducci; D Burroni; M Bugnoli; M F Tecce; S Censini; A Covacci; Z Xiang
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

View more
  5 in total

1.  Antibody-secreting cells in the stomachs of symptomatic and asymptomatic Helicobacter pylori-infected subjects.

Authors:  A Mattsson; M Quiding-Järbrink; H Lönroth; A Hamlet; I Ahlstedt; A Svennerholm
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

2.  Helicobacter pylori infection and gastric function in patients with fundic atrophic gastritis.

Authors:  A Tucci; L Poli; G Biasco; G F Paparo; C Tosetti; P Fusaroli; V Sambri; M Donati; W Grigioni; A M Labate; V Stanghellini; G Caletti
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

3.  Serological assays for identification of human gastric colonization by Helicobacter pylori strains expressing VacA m1 or m2.

Authors:  Chandrabali Ghose; Guillermo I Perez-Perez; Victor J Torres; Marialuisa Crosatti; Abraham Nomura; Richard M Peek; Timothy L Cover; Fritz Francois; Martin J Blaser
Journal:  Clin Vaccine Immunol       Date:  2007-01-31

4.  PCR-based restriction pattern typing of the vacA gene provides evidence for a homogeneous group among Helicobacter pylori strains associated with peptic ulcer disease.

Authors:  M Donati; E Storni; L D'Apote; S Moreno; A Tucci; L Poli; R Cevenini
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

5.  Association of CagA and VacA presence with ulcer and non-ulcer dyspepsia in a Turkish population.

Authors:  Kantarceken Bulent; Aladag Murat; Atik Esin; Koksal Fatih; Harputluoglu MMMurat; Harputluoglu Hakan; Karincaoglu Melih; Ates Mehmet; Yildirim Bulent; Hilmioglu Fatih
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.